Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000881459 | SCV001024637 | likely benign | not provided | 2025-01-29 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001002008 | SCV001159824 | uncertain significance | Charcot-Marie-Tooth disease type 4B3 | 2020-01-09 | criteria provided, single submitter | clinical testing | The SBF1 c.2393A>G; p.Asn798Ser variant (rs199705951), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 709964). This variant is found in the African population with an overall allele frequency of 0.7% (179/23900 alleles, including a single homozygote) in the Genome Aggregation Database. The asparagine at codon 798 is highly conserved, but computational analyses (SIFT: tolerated, PolyPhen-2: possibly damaging) predict conflicting effects of this variant on protein structure/function. Due to limited information, the clinical significance of the p.Asn798Ser variant is uncertain at this time. |
Mayo Clinic Laboratories, |
RCV000881459 | SCV005410311 | uncertain significance | not provided | 2024-03-19 | criteria provided, single submitter | clinical testing | BS1 |
Prevention |
RCV003948312 | SCV004758233 | benign | SBF1-related disorder | 2022-08-29 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |